Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia

LEUKEMIA

NATURE PUBLISHING GROUP

1. Intramural NIH HHS [ZIA HL002346-09] Funding Source: Medline
2. NCI NIH HHS [P50 CA13080503] Funding Source: Medline